Connective Tissue Diseases and Vasculitis (Behçet’s Disease and Other Vasculitis in the Elderly)
Özet
Connective tissue diseases and vasculitis in the elderly present unique diagnostic and therapeutic challenges due to age-related immune changes, comorbidities, and polypharmacy. Dermatomyositis shows a bimodal age distribution, with an increased risk of associated malignancies in elderly patients, particularly lung, ovarian, breast, and gastrointestinal cancers. Typical clinical features include cutaneous manifestations and progressive muscle weakness, often with a chronic course in older adults. Systemic lupus erythematosus (SLE) in the elderly, termed late-onset SLE, presents with more benign disease activity but often delayed diagnosis due to nonspecific symptoms such as fatigue and weight loss. Elderly SLE patients more frequently develop serositis, Sjogren-like symptoms, and have less classical malar rash and renal involvement, necessitating careful differentiation from malignancies and endocrine disorders. Sjogren’s syndrome also occurs in older adults, with a milder clinical course but frequent sicca symptoms often misattributed to aging or medications. Vasculitis in this population includes primary forms like giant cell arteritis and ANCA-associated vasculitis, as well as secondary vasculitis linked to connective tissue diseases, malignancies, infections, and drugs. Treatment strategies require balancing immunosuppression efficacy and side effect risks, particularly glucocorticoid toxicity and infection susceptibility. Awareness of these complex overlapping syndromes is essential for optimizing care in elderly patients.
Referanslar
Lahaye C, Tatar Z, Dubost JJ, Tournadre A, Soubrier M. Management of inflammatory rheumatic conditions in the elderly. Rheumatology (Oxford). 2019 May 1;58(5):748-764. doi: 10.1093/rheumatology/key165. PMID: 29982766; PMCID: PMC6477520.
Langford CA. Vasculitis in the geriatric population. Rheum Dis Clin North Am. 2007 Feb;33(1):177-95. doi: 10.1016/j.rdc.2006.12.002. PMID: 17367699.
Gloor AD, Berry GJ, Goronzy JJ, Weyand CM. Age as a risk factor in vasculitis. Semin Immunopathol. 2022 May;44(3):281-301. doi: 10.1007/s00281-022-00911-1. Epub 2022 Feb 9. PMID: 35141865; PMCID: PMC9064861.
Morinaka S, Tsuboi H, Hagiwara S, Sugita T, Tabuchi D, Sato R, Nishiyama T, Okamoto S, Terasaki T, Yagishita M, Takahashi H, Kondo Y, Matsumoto I, Sumida T. Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset. Mod Rheumatol. 2021 Nov;31(6):1129-1134. doi: 10.1080/14397595.2021.1878622. Epub 2021 Feb 22. PMID: 33480825.
Parry R, Sherwin S, Fletcher V, Medcalf P. ANCA-associated vasculitis: diagnosis and treatment in the elderly. Postgrad Med J. 1996 Jul;72(849):423-6. doi: 10.1136/pgmj.72.849.423. PMID: 8935603; PMCID: PMC2398524.
Hoganson DD, From AM, Michet CJ. ANCA vasculitis in the elderly. J Clin Rheumatol. 2008 Apr;14(2):78-81. doi: 10.1097/RHU.0b013e31816b2fbd. PMID: 18391675.
Meng T, Zhong Y, Chen J, Zhou YO, Zuo X, Luo H, Lin W, Wu T, Yang Y, Xiao Z, Tang R, Ao X, Xiao X, Zhou Q, Xiao P. Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese elderly and very elderly patients. Int Urol Nephrol. 2021 Sep;53(9):1875-1881. doi: 10.1007/s11255-021-02786-x. Epub 2021 Mar 6. PMID: 33675470.
Sada KE, Ohashi K, Asano Y, Hayashi K, Morishita M, Watanabe H, Matsumoto Y, Fujimoto S, Takasaki Y, Yamagata K, Banno S, Dobashi H, Amano K, Harigai M, Arimura Y, Makino H; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS) and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan. Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies. Arthritis Res Ther. 2020 Oct 12;22(1):236. doi: 10.1186/s13075-020-02341-6. PMID: 33046139; PMCID: PMC7552473.
Harada M, Yamaguchi A, Sonoda K, Yamada Y, Aomura D, Kamimura Y, Hashimoto K, Ichikawa T, Kobayashi M, Kamijo Y. Comparison of the factors associated with the short-term prognosis between elderly and non-elderly patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective observational study. Clin Exp Rheumatol. 2022 May;40(4):705-713. doi: 10.55563/clinexprheumatol/3qb95d. Epub 2021 Sep 9. PMID: 34524078.
Honda N, Yokogawa N. Clinical Characteristics and Outcomes of IgA Vasculitis in the Elderly. J Clin Rheumatol. 2022 Sep 1;28(6):325-327. doi: 10.1097/RHU.0000000000001828. Epub 2022 Jan 24. PMID: 35067511.
Ziadé N, Awada H. Late onset Behçet's disease. Joint Bone Spine. 2006 Oct;73(5):567-9. doi: 10.1016/j.jbspin.2006.06.002. Epub 2006 Jul 14. PMID: 16904928.
Karube H, Kamoi K, Ohno-Matsui K. Anti-TNF therapy in the management of ocular attacks in an elderly patient with long-standing Behçet's disease. Int Med Case Rep J. 2016 Sep 27;9:301-304. doi: 10.2147/IMCRJ.S117731. PMID: 27729816; PMCID: PMC5045905.
Nishimura K, Hamasaki T, Yamamoto S, Kawai T, Sugiura K. Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease. Ann Vasc Dis. 2015;8(4):328-30. doi: 10.3400/avd.cr.15-00082. Epub 2015 Oct 15. PMID: 26730261; PMCID: PMC4691510.
Shiraishi W, Tsujimoto Y, Matsuyoshi A, et al. BMJ Case Rep 2023;16:e252033. doi:10.1136/bcr-2022- 252033
Yilmaz-Oner S, Can M, Ozen G, Oz B, Baltacioglu F, Tuzun H, Direskeneli H. An unusual case with vasculo-Behçet's disease: peripheral arterial aneurysm in an elderly woman. Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S103-5. Epub 2013 Dec 2. PMID: 24295361.
Awaji K, Inokuchi R, Maehara H, Moriyama M, Ohmae T, Okamoto M, Suyama Y. Gastrointestinal Behçet's disease: periodic fever, multiple ulcers and trisomy 8 in elderly man. QJM. 2018 Aug 1;111(8):579-580. doi: 10.1093/qjmed/hcy041. PMID: 29474736.
Waldman R, DeWane ME, Lu J. Dermatomyositis: Diagnosis and treatment. J Am Acad Dermatol. 2020 Feb;82(2):283-296. doi: 10.1016/j.jaad.2019.05.105. Epub 2019 Jul 4. PMID: 31279813.
de Souza FH, Shinjo SK. Newly diagnosed dermatomyositis in the elderly as predictor of malignancy. Rev Bras Reumatol. 2012 Oct;52(5):713-21. English, Portuguese. PMID: 23090371.
Norman RA, Blanco PM. Papulosquamous diseases in the elderly. Dermatol Ther. 2003;16(3):231-42. doi: 10.1046/j.1529-8019.2003.01633.x. PMID: 14510880.
Pautas E, Chérin P, Piette JC, Pelletier S, Wechsler B, Cabane J, Herson S. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Clin Exp Rheumatol. 2000 Mar-Apr;18(2):241-4. PMID: 10812498.
Rovenský J, Tuchynová A. Systemic lupus erythematosus in the elderly. Autoimmun Rev. 2008 Jan;7(3):235-9. doi: 10.1016/j.autrev.2007.11.014. Epub 2007 Dec 3. PMID: 18190884.
Lazaro D. Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging. 2007;24(9):701-15. doi: 10.2165/00002512-200724090-00001. PMID: 17727302.
Fettig J, Desiderio M, Nagarajan V. Elderly-onset systemic lupus erythematosus. J Am Geriatr Soc. 2013 Sep;61(9):1634-5. doi: 10.1111/jgs.12425. PMID: 24028369.
Shinjo SK. Systemic lupus erythematosus in the elderly: antimalarials in disease remission. Rheumatol Int. 2009 Jul;29(9):1087-90. doi: 10.1007/s00296-009-0907-6. Epub 2009 Apr 8. PMID: 19352682.
Medhat BM, Behiry ME, Sobhy N, Farag Y, Marzouk H, Mostafa N, Khalifa I, Elkhalifa M, Eissa BM, Hassan EHE. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort. Clin Rheumatol. 2020 Feb;39(2):435-442. doi: 10.1007/s10067-019-04776-y. Epub 2019 Nov 22. PMID: 31758421.
Al-Hashimi I. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management. Drugs Aging. 2005;22(11):887-99. doi: 10.2165/00002512-200522110-00001. PMID: 16323968.
Baer AN, Walitt B. Update on Sjögren Syndrome and Other Causes of Sicca in Older Adults. Rheum Dis Clin North Am. 2018 Aug;44(3):419-436. doi: 10.1016/j.rdc.2018.03.002. PMID: 30001784; PMCID: PMC6245643.
Baer AN, Walitt B. Sjögren Syndrome and Other Causes of Sicca in Older Adults. Clin Geriatr Med. 2017 Feb;33(1):87-103. doi: 10.1016/j.cger.2016.08.007. PMID: 27886700; PMCID: PMC5125547.
Ng KP, Isenberg DA. Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly. Drugs Aging. 2008;25(1):19-33. doi: 10.2165/00002512-200825010-00003. PMID: 18184026.
Moerman RV, Bootsma H, Kroese FG, Vissink A. Sjögren's syndrome in older patients: aetiology, diagnosis and management. Drugs Aging. 2013 Mar;30(3):137-53. doi: 10.1007/s40266-013-0050-7. PMID: 23341116.
García-Carrasco M, Cervera R, Rosas J, Ramos-Casals M, Morlà RM, Sisó A, Jiménez S, Pallarés L, Font J, Ingelmo M. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus. 1999;8(1):20-3. doi: 10.1191/096120399678847353. PMID: 10025595.
